Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Dr. Michael A. Pritchett

Pulmonary Medicine
Mcpc-18, LLC
205 Page Rd, 
Pinehurst, NC 
Accepting New Patients
Offers Telehealth
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Mcpc-18, LLC
205 Page Rd, 
Pinehurst, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Pritchett is a Pulmonary Medicine provider in Pinehurst, North Carolina. Dr. Pritchett is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Lung Nodules, Lung Cancer, Lung Metastases, Advanced Bronchoscopy, and Endoscopy. Dr. Pritchett is currently accepting new patients.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in NC
Hospital Affiliations
Firsthealth Moore Regional Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

MCPC-18, LLC
205 Page Rd, Pinehurst, NC 28374
Other Locations
PINEHURST MEDICAL CLINIC INC
8 Regional Cir, Pinehurst, NC 28374

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Secondary Soft Tissue Lesions of the Lung
A Multicenter Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Secondary Soft Tissue Lesions of the Lung
Enrollment Status: Withdrawn
Publish Date: June 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

34 Total Publications

The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer.
The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer.
Journal: Journal of bronchology & interventional pulmonology
Published: January 29, 2025
Similar Doctors
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Adam R. Belanger
Pulmonary Medicine | Intensive Care Medicine
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Adam R. Belanger
Pulmonary Medicine | Intensive Care Medicine

Mcpc-18, LLC

155 Memorial Dr, 
Pinehurst, NC 
 (0.2 miles away)
910-715-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Adam Belanger is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Pinehurst, North Carolina. Dr. Belanger is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Lung Nodules, Lung Metastases, Squamous Cell Lung Carcinoma, Endoscopy, and Advanced Bronchoscopy. Dr. Belanger is currently accepting new patients.

Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Hubert J. Ford
Pulmonary Medicine | Intensive Care Medicine
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Hubert J. Ford
Pulmonary Medicine | Intensive Care Medicine

University Of North Carolina At Chapel Hill

6715 Mccrimmon Pkwy, 
Cary, NC 
 (53.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hubert Ford is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Cary, North Carolina. Dr. Ford is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Neurosarcoidosis. Dr. Ford is currently accepting new patients.

Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Sonal Arora
Pulmonary Medicine
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Sonal Arora
Pulmonary Medicine

Teamwork Health PLLC

115 Kildaire Park Dr, Suite 309, 
Cary, NC 
 (53.0 miles away)
910-491-6793
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sonal Arora is a Pulmonary Medicine provider in Cary, North Carolina. Dr. Arora is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Lung Metastases, Emphysema, Obstructive Sleep Apnea, and Bullae. Dr. Arora is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pritchett's expertise for a condition
ConditionClose
View All 22 Distinguished Conditions
View All 16 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile